Perspectives on the Treatment of Multiple Myeloma
The treatment of multiple myeloma has evolved significantly over the past few decades with
the development of novel therapeutics. The introduction of proteasome inhibitors …
the development of novel therapeutics. The introduction of proteasome inhibitors …
The core symptom in multiple myeloma patients undergoing chemotherapy: a network analysis
L Zeng, H Huang, Y Liu, C Ruan, S Fan, Y Xia… - Supportive Care in …, 2023 - Springer
Background During chemotherapy for multiple myeloma, symptoms include those related to
the disease, as well as adverse effects of the treatment. Few studies have explored the …
the disease, as well as adverse effects of the treatment. Few studies have explored the …
Multiple myeloma patients undergoing chemotherapy: Which symptom clusters impact quality of life?
L Zeng, H Huang, C Qirong, C Ruan… - Journal of Clinical …, 2023 - Wiley Online Library
Abstract Aims and Objectives To identify symptom clusters and examine their association
with health‐related quality of life. Background Multiple myeloma patients undergoing …
with health‐related quality of life. Background Multiple myeloma patients undergoing …
Cell division cycle 37 change after bortezomib-based induction therapy helps to predict clinical response and prognosis in multiple myeloma patients
W Lin, X Chen, H Zheng, Z Cai - Hematology, 2023 - Taylor & Francis
Objective Cell division cycle 37 (CDC37) modulates disease progression and bortezomib
resistance in multiple myeloma by regulating X-box binding protein 1, nuclear factor-kappa …
resistance in multiple myeloma by regulating X-box binding protein 1, nuclear factor-kappa …